Join the DDA or

Various MHRA safety alerts

Three affected products

September 4th 2023

Tagged: MHRA alert


MHRA has issued various safety alerts:

Class 2: Veriton Pharma Limited, Epistatus 2.5 mg oromucosal solution, pre-filled syringe  (Veriton Pharma Limited)

One affected batch is being recalled:

Batch NumberExpiry DatePack SizeFirst Distributed
230327A209/20241 x 0.25ml PFS05/06/2023

Active Pharmaceutical Ingredient: Each pre-filled oral syringe contains 0.25ml of

The affected batch has the potential for some products to appear cloudy and/or contain crystalline particles.

Class 4 Medicines Defect Information: Kyowa Kirin Limited, Tostran (Testosterone, 2% gel)

In seven affected batches the priming instructions in the current PIL for Tostran 2% gel require updating to ensure an accurate first dose may be delivered. The Patient Information Leaflet and Summary Product Information will be updated.

Class 4 Medicines Defect Information: Galderma (U.K.) Limited, Loceryl 5% w/v Medicated Nail Lacquer (5.0 ml)

The following affected batch is licensed only for distribution in Ireland. Although Loceryl is a registered medicine in both Ireland and the UK, there are differences between these products in the product labelling and Patient Information Leaflet (PIL) packaged with the medicine.

Batch NoExpiry DatePack SizeFirst Distributed
2212421*05 / 20251 x 5.0ml19 August 2022